Severe liver degeneration and lack of NFB activation in NEMO/IKKγ-deficient mice

  1. Dorothea Rudolph1,
  2. Wen-Chen Yeh1,
  3. Andrew Wakeham1,
  4. Bettina Rudolph2,
  5. Dhani Nallainathan1,
  6. Julia Potter1,
  7. Andrew J. Elia1, and
  8. Tak W. Mak1,3
  1. 1The Amgen Institute, Ontario Cancer Institute, and Departments of Medical Biophysics and Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada; 2Imperial Cancer Research Fund, WC2A 3PX London, UK

Abstract

Phosphorylation of IκB, an inhibitor ofNF-κB, is an important step in the activation of the transcription factor NF-κB. Phosphorylation is mediated by the IκB kinase (IKK) complex, known to contain two catalytic subunits: IKKα andIKKβ. A novel, noncatalytic component of this kinase complex called NEMO( N F-κB essentialmodulator)/IKKγ was identified recently. We have generatedNEMO/IKKγ-deficient mice by gene targeting. Mutant embryos die at E12.5–E13.0 from severe liver damage due to apoptosis.NEMO/IKKγ-deficient primary murine embryonic fibroblasts (MEFs) lack detectableNF-κB DNA-binding activity in response to TNFα, IL-1, LPS, and Poly(IC) and do not show stimulus-dependent IκB kinase activity, which correlates with a lack of phosphorylation and degradation of IκBα. Consistent with these data, mutant MEFs show increased sensitivity to TNFα-induced apoptosis. Our data provide in vivo evidence that NEMO/IKKγ is the first essential, noncatalytic component of the IKK complex.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL t.mak{at}oci.utoronto.ca; FAX (416) 204-2278.

    • Received November 16, 1999.
    • Accepted February 23, 2000.
| Table of Contents

Life Science Alliance